Placing HIV prevention options for young women in the context of sexual and reproductive health
2 March 2016 – The results of two recent clinical trials showed that the use of a vaginal ring, containing the HIV prevention drug Dapivirine, reduced women’s risk of HIV infection overall by 27 percent. The trials showed, however, that there was no protective effect in young women between the ages of 18 and 21.
1 DEC 2015. WORLD AIDS DAY ¦ Women living with HIV can achieve safe and satisfying sexual lives, but there is still much to do for this to be a reality for the most vulnerable who face repeated violations of their rights. Antiretroviral treatment, together with advances in overcoming stigma and discrimination, and the development of HIV prevention interventions have all given hope and a chance at a healthy life for many around the world. For those who remain the most vulnerable, however, there is not nearly enough progress. Many women and girls living with HIV remain vulnerable due to a host of biological, social, cultural and economic reasons, including women’s continued social and economic inequality.
Linkages between sexual and reproductive health (SRH) and HIV
"Men build too many walls and not enough bridges", Isaac Newton.
Linkages, or the policy, programmes, services and advocacy synergies between SRH and HIV are approaches that have the potential to increase universal access to both sexual and reproductive health as well as HIV prevention and care.
SRH/HIV: Access to and coverage of services
By minimizing missed opportunities we can increase access and coverage of services for more people including vulnerable populations, and ensure services for people living with HIV that meet their needs and respect their rights.